AMOUN PHARMACEUTICAL

Amoun’s main business includes development, manufacturing, marketing, distribution, and export of a wide range of human pharmaceutical and animal health products. Amoun maintains a robust product portfolio that offers a wide range of much needed pharmaceutical therapies and treatments. With a strong product pipeline strategy, Amoun currently has more than 30 new product at various stages of registration that were carefully selected in order to address many un-met therapeutic needs, such as high prevalence diseases and other diseases of high national interest. Amoun’s product portfolio and product pipeline will endure further expansions for many years to come and will continue to play a major role in driving growth and in increasing shareholders’ value.